期刊文献+

PD-1/PD-L1在三阴性乳腺癌中的表达及其意义 被引量:23

Expression of PD-1/PD-L1 in triple-negative breast carcinoma and its significance
原文传递
导出
摘要 目的:探讨程序性死亡分子1(PD-1)和程序性死亡配体1(PD-L1)在三阴性乳腺癌中的表达及其与临床病理特征的相关性。方法采用组织芯片结合免疫组织化学方法对151例三阴性乳腺癌(病例组)及65例非三阴性乳腺癌(对照组)进行染色,观察PD-1/PD-L1在各组的表达情况,分析其与各临床病理特征的关系。结果病例组肿瘤细胞和间质肿瘤浸润淋巴细胞中PD-1/PD-L1的表达均高于对照组,差异有统计学意义( P <0.05)。其中,肿瘤细胞 PD-L1阳性率为16.6%(25/151),与高组织学级别、淋巴结转移相关(均P<0.05);间质肿瘤浸润淋巴细胞PD-L1阳性率为25.2%(38/151),与高组织学级别相关(P<0.05)。间质肿瘤浸润淋巴细胞PD-1阳性率为27.2%(41/151),与间质肿瘤浸润淋巴细胞PD-L1表达呈正相关(P<0.05)。结论 PD-L1在三阴性乳腺癌的表达与高组织学级别、淋巴结转移、间质肿瘤浸润淋巴细胞PD-1阳性相关。 Objective To investigate the correlation between the expression of PD-1, PD-L1 and clinicopathologic parameters in triple negative breast carcinoma ( TNBC ) .Methods Samples from 151 patients with TNBC and 65 cases of other breast carcinomas ( non-TNBC) were examined for PD-L1 and PD-1 expression by immunohistochemical staining on tissue microarray .Results The expression of PD-L1 and PD-1 in the tumor cells and interstitial lymphocytes in TNBC was significantly ( P〈0.05 ) higher than that in non-TNBC.In TNBC, the expression rates of PD-L1 in the cancer nests and stroma were 16.6%(25/151) and 25.2%(38/151) respectively.The former was positively correlated with tumor histological grade and lymph node metastasis (P〈0.05), and the latter only with tumor histological grade (P〈0.05). The expression rate of PD-1 was 27.2%(41/151), and correlated with PD-L1 expression in stromal tumor-infiltrating lymphocytes ( P 〈0.05 ) .Conclusion The expression of PD-L1 in TNBC is significantly correlated with high-grade histology , lymph node metastasis and PD-L1 expression in stromal tumor-infiltrating lymphocytes .
作者 张伟 徐国祥 李佳嘉 刘霞 陈玉娟 张帆 Zhang Wei Xu Guoxiang Li Jiajia Liu Xia Chen Yujuan Zhang Fan(Department of Pathology, Wannan Medical College Yijishan Hospital, Wuhu 241001, China)
出处 《中华病理学杂志》 CAS CSCD 北大核心 2017年第1期20-24,共5页 Chinese Journal of Pathology
关键词 乳腺肿瘤 淋巴细胞 肿瘤浸润 免疫组织化学 Breast neoplasms Lymphocytes,tumor-infiltrating Immunohistochemistry
  • 相关文献

参考文献4

二级参考文献55

  • 1张瑰红,施达仁,梁晓曼,侯景辉,康苏娅,朱卫东,李晓兵,邵云,陈丽荣,周燕.显色原位杂交和免疫组织化学检测乳腺癌HER2/neu基因状况和蛋白表达的对照性研究[J].中华病理学杂志,2006,35(10):580-583. 被引量:29
  • 2<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 3Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-HI promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med, 2002, 8:793-800.
  • 4Strome SE, Dong H, Tamura H, et al. BT-HI blockade auguments adoptive T-cell immunotherapy for squamous cell carcinoma, Cancer Res, 2003, 63:6501-6505.
  • 5Konishi J, Yamazaki K, Azuma M, et al. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumorinfiltrating lymphocytes and their PD-1 expression. Clin Cancer Res, 2004, 10:5094-5100.
  • 6Ohigashil Y, Sho M, Yamada Y, et al. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res, 2005, 11:2947-2953.
  • 7Nomi T, Sho M, Akahori T, et al. Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res, 2007, 13 : 2151-2157.
  • 8Cho Y, Miyamoto M, Kato K, et al. CD4^+ and CD8^+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res, 2003, 63 : 1555-1559.
  • 9Ropponen KM, Eskelinen MJ, Lipponen PK, et al. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol, 1997, 182:318-324.
  • 10Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol, 2005, 23:515-548.

共引文献388

同被引文献85

引证文献23

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部